Liu, D.; Zhao, L.; Wang, Y.; Wang, L.; Wu, D.; Liu, Y.
Berberine: A Rising Star in the Management of Type 2 Diabetes—Novel Insights into Its Anti-Inflammatory, Metabolic, and Epigenetic Mechanisms. Pharmaceuticals 2025, 18, 1890.
https://doi.org/10.3390/ph18121890
AMA Style
Liu D, Zhao L, Wang Y, Wang L, Wu D, Liu Y.
Berberine: A Rising Star in the Management of Type 2 Diabetes—Novel Insights into Its Anti-Inflammatory, Metabolic, and Epigenetic Mechanisms. Pharmaceuticals. 2025; 18(12):1890.
https://doi.org/10.3390/ph18121890
Chicago/Turabian Style
Liu, Da, Liting Zhao, Ying Wang, Lei Wang, Donglu Wu, and Yangyang Liu.
2025. "Berberine: A Rising Star in the Management of Type 2 Diabetes—Novel Insights into Its Anti-Inflammatory, Metabolic, and Epigenetic Mechanisms" Pharmaceuticals 18, no. 12: 1890.
https://doi.org/10.3390/ph18121890
APA Style
Liu, D., Zhao, L., Wang, Y., Wang, L., Wu, D., & Liu, Y.
(2025). Berberine: A Rising Star in the Management of Type 2 Diabetes—Novel Insights into Its Anti-Inflammatory, Metabolic, and Epigenetic Mechanisms. Pharmaceuticals, 18(12), 1890.
https://doi.org/10.3390/ph18121890